Prepare Yourself for Liftoff: Aurinia Pharmaceuticals Inc (AUPH)

With 1.64 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.47 million shares. The 52-week range on AUPH shows that it touched its highest point at $10.67 and its lowest point at $4.71 during that stretch. It currently has a 1-year price target of $9.83. Beta for the stock currently stands at 1.24.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AUPH was up-trending over the past week, with a rise of 2.38%, but this was up by 0.99% over a month. Three-month performance dropped to -6.31% while six-month performance rose 18.23%. The stock gained 48.01% in the past year, while it has lost -9.02% so far this year. A look at the trailing 12-month EPS for AUPH yields 0.04 with Next year EPS estimates of 0.75. For the next quarter, that number is 0.10. This implies an EPS growth rate of 1015.00% for this year and 68.16% for next year.

Float and Shares Shorts:

At present, 140.88 million AUPH shares are outstanding with a float of 122.11 million shares on hand for trading.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AUPH since 3 analysts follow the stock currently. There are 2 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $0.1144 being high and -$0.026 being low. For AUPH, this leads to a yearly average estimate of $0.026. Based on analyst estimates, the high estimate for the next quarter is $0.14 and the low estimate is $0.08. The average estimate for the next quarter is thus $0.11.